Eritropoyetina, insuficiencia renal crónica y cáncer .. A insuficiência renal crônica (IRC) é uma enfermidade que provoca a perda parcial ou total da função . Métodología de cuantificación de eritropoyetina. Uploaded . La administración de eritropoyetina Beta y muestras de sangre de todos los . IRC Mecanismos. Los riñones sanos producen una hormona llamada eritropoyetina (EPO). La EPO envía una señal al cuerpo para que produzca más células rojas sanguíneas.
|Published (Last):||21 June 2010|
|PDF File Size:||12.90 Mb|
|ePub File Size:||7.84 Mb|
|Price:||Free* [*Free Regsitration Required]|
Show more Show less.
There was a problem providing the content you requested
Print Send to a friend Export reference Mendeley Statistics. Indicaciones de la eritropoyetina recombinante. You can change the settings or obtain more information by clicking here. From Monday to Friday from 9 a.
The utilization of rHuEp changed definitively the treatment and the natural history of anemia in patients with chronic renal insufficiency CRIand now is modifying the treatment of anemia of other non-renal patients as anemia of premature, anemia in onco-hematological illnesses, anemia in human immunodeficiency virus HIV infection, and for reduction of allogenic blood transfusions in surgery.
Continuing navigation will be considered as acceptance of this use.
[Anemia in chronic kidney disease].
Si continua navegando, consideramos que acepta su uso. Complexo Hospitalario Universitario Juan Canalejo. CiteScore measures average citations received per document published. Although the cause is multi-factorial, the most known is inadequate erythropoietin production.
SJR uses a similar algorithm as the Google page rank; it provides a quantitative and qualitative measure of the journal’s impact. Nine issues are published each year, including mostly originals, reviews and consensus documents.
eritropoyetina en irc pdf
In eritropoyetna trials, the achievement of normal or nearly normal hemoglobin levels is not associated with improved eritroppyetina and reduced cardiovascular risk; however the ideal hemoglobin level with the use of erythropoiesis-stimulating agents seems to be problematic.
The Impact Factor measures the average number of citations received in a particular year by papers published in the journal during the two receding years. More information is needed in order to obtain definite conclusions; in the meantime, using the lowest possible dose of erythropoietin seems to be the most prudent approach. Treatment with erythropoiesis-stimulating agents, such as erythropoietin, is a logical strategy that has enabled clinical improvement and reduced transfusion requirements for the patients; however, total correction of anemia with erythropoiesis-stimulating agents has demonstrated an increase in the risk of mortality or cardiovascular complications associated with these agents.
SRJ is a prestige metric based on the idea that not itc citations are the same.
Ric de respuesta ineficaz a la eritropoyetina recombinante. Anemia is almost unavoidable in the last stages of chronic kidney disease. Universidad de Santiago de Compostela.
Anemia has been associated with poor prognosis in patients with several conditions such as cancer, chronic kidney disease and congestive heart failure. The journal fully endorses the goals of updating knowledge and facilitating the acquisition of key developments in internal medicine applied to clinical practice. This item has received. Subscriber If you already have your login data, please click here.
SNIP measures contextual citation impact by wighting citations based on the total number of citations in a subject field. To improve our services and products, we use “cookies” own or third parties authorized to show advertising related to client preferences through the analyses of navigation customer behavior.
Previous article Next article. Subscribe to our Newsletter. We analyze briefly the clinical indications of rHuEpo and the possible complications secondary to its use.
Are you a health professional able to prescribe or dispense drugs? July Pages New indications for erythropoietin in clinical practice.